STIFEL FINANCIAL CORP - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$338,592
-37.0%
147,212
-0.1%
0.00%
-100.0%
Q2 2023$537,722
+2.8%
147,321
+0.6%
0.00%0.0%
Q1 2023$522,879
+40.7%
146,464
+12.4%
0.00%0.0%
Q4 2022$371,538
+151.0%
130,363
+95.6%
0.00%
Q3 2022$148,000
-10.3%
66,6560.0%0.00%
Q2 2022$165,000
-49.2%
66,6560.0%0.00%
Q1 2022$325,000
-56.9%
66,6560.0%0.00%
-100.0%
Q4 2021$754,000
-21.5%
66,656
+1.2%
0.00%0.0%
Q3 2021$960,000
+25.0%
65,8860.0%0.00%0.0%
Q2 2021$768,000
-4.5%
65,8860.0%0.00%0.0%
Q1 2021$804,000
-2.4%
65,8860.0%0.00%0.0%
Q4 2020$824,000
-16.9%
65,8860.0%0.00%
-50.0%
Q3 2020$991,000
-38.6%
65,8860.0%0.00%
-50.0%
Q2 2020$1,615,000
+103.9%
65,886
+18.0%
0.00%
+100.0%
Q1 2020$792,000
-10.7%
55,8550.0%0.00%0.0%
Q4 2019$887,000
+88.3%
55,8550.0%0.00%
+100.0%
Q3 2019$471,000
-6.2%
55,8550.0%0.00%0.0%
Q2 2019$502,00055,8550.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,437,445$21,634,00010.97%
Prosight Management, LP 709,936$10,685,0005.08%
Voss Capital, LLC 226,573$3,410,0001.94%
Robertson Stephens Wealth Management, LLC 484,000$7,284,0001.79%
Slate Path Capital LP 1,483,619$22,328,0001.27%
Nantahala Capital Management 2,342,216$35,250,0001.08%
SANDERS MORRIS HARRIS LLC 142,430$2,312,0000.63%
Rock Creek Group, LP 80,000$1,204,0000.62%
PRECEPT MANAGEMENT LLC 150,000$2,258,0000.55%
PA Capital LLC 46,850$705,0000.50%
View complete list of CUE BIOPHARMA INC shareholders